agreed, this stock has been a capital killer. without some growing revenue we are just an overpriced consulting business.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025